Table 1. Characteristics of study participants by village.
| Village | N | % female | Mean age (±SD) | Mean weight (±SD) | % LLIN use at enrolment* | Mean LLIN use during follow-up†
(%, range) |
Mean Hb (±SD) |
|---|---|---|---|---|---|---|---|
| Amahup | 119 | 53 | 7.6 (±1.5) | 19.8 (±3.3) | 99 | 99 (50–100) | 11.1 (±1.0) |
| Albinama | 99 | 43 | 7.7 (±1.5) | 20.0 (±3.3) | 95 | 97 (78–100) | 11.7 (±1.8) |
| Balanga | 54 | 59 | 7.8 (±1.6) | 19.8 (±4.3) | 96 | 99 (83–100) | 11.3 (±1.1) |
| Balif | 93 | 51 | 7.8 (±1.5) | 20.3 (±3.3) | 91 | 99 (69–100) | 11.7 (±1.2) |
| Bolumita | 70 | 50 | 7.4 (±1.7) | 19.3 (±2.9) | 77 | 92 (56–100) | 10.7 (±1.0) |
| Numangu | 31 | 55 | 7.4 (±1.6) | 19.2 (±4.6) | 100 | 100 (92–100) | 12.1 (±1.4) |
| Total | 466 | 51 | 7.6 (±1.5) | 19.8 (±3.5) | 93 | 100 (50–100) | 11.4 (±1.4) |
* LLIN use in the night preceding enrolment.
† Information on LLIN use in the previous night was collected at each follow-up visit and averaged across follow-up per participant. Mean LLIN use by village was calculated from the averaged individual LLIN use.
Hb: Haemoglobin.